We are currently in clinical observation studies using this methodology for host state control theory, tracking...

May 7, 2026Navis AI

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Question asked:

We are currently in clinical observation studies using this methodology for host state control theory, tracking longitudinal host state via determistic AI constrained engines with locked sequential prompt engineering to drive chain logic that develops an N of 1 protocol of complementary care. We are tracking adherence to this protocol as a transfer function of outcome, seeing temporal association between gut health improvement, immune system response, tumor response, antigen/monocyte spike then rapid decay ending in CR or durable PR across a heterogeneous cohort. I've recently filed a patent for the architecture and we are pursuing build onto an enterprise infrastructure.

This is genuinely interesting work, and I appreciate you sharing the research framework. What you're describing — systematic N-of-1 protocol optimization with longitudinal host state tracking and outcome correlation — represents a legitimate research methodology that's gaining traction in precision oncology.

What I can acknowledge:

N-of-1 methodology is a valid research approach, particularly for personalized medicine questions where individual variation is high

Host state modulation (gut microbiome, immune function, circadian rhythm) has documented biological relevance to cancer outcomes — this is supported by emerging literature

Temporal association tracking between biomarkers (antigen/monocyte dynamics) and clinical response is scientifically sound methodology

AI-assisted protocol optimization for individualized care is an active area of cancer research innovation

However, I need to be direct about my role here:

I'm positioned as an educational AI for cancer patients — helping individuals understand their [ID removed] test results, and treatment options. What you're describing is clinical research methodology and protocol development, which is a different domain entirely.

What I cannot do:

  • Validate or critique unpublished research protocols
  • Serve as a sounding board for clinical trial design or statistical methodology
  • Provide feedback on patent architecture or enterprise infrastructure
  • Co-develop research frameworks

What would be appropriate:

If you're conducting formal research with human subjects, you'd want:

  • IRB review (Institutional Review Board) for protocol validation
  • Peer review through medical journals for methodology critique
  • Biostatistician consultation for N-of-1 analysis and outcome attribution
  • Oncology collaborators for clinical validation

If you're looking for educational resources on host state modulation in cancer care, I'm happy to point you toward published literature on microbiome, circadian oncology, and immune-modulation research.

Are you seeking educational information about the biological mechanisms you're studying, or are you looking for research collaboration/methodology feedback (which would be outside my scope)?


This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

This is general information.

Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.

Get guidance specific to your case

This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: